HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Gardaí search for teenage boy missing since Saturday

British MP says Catholics in the North 'urged direct rule' weeks ago

Pregnant woman aged 20 died of 'extraordinarily rare, catastrophic cascade of events'

Court takes 3-and-a-half hours to select jury for trial of men accused of Joan Burton's false imprisonment


Today's Stories

Discovery paves way for multiple sclerosis treatments

Kathleen Lynch to contest next election despite ‘bruising’ defeat

‘No room at the inn’ for tourism workers

Up to two consultants a month quit

Lifestyle

Speaking up on mental health to challenge the stigma of schizophrenia

Prine Harry opens up about pain following his mother's death

Vandalism of landscape and natural history

5 things to do this week

More From The Irish Examiner